Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EEG-acp

K-Number: K212325 · 2022-06-15

Decision Date2022-06-15
Product CodeGYB
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

EEG-acp is the device name listed in this FDA 510(k) record. The listed applicant is Somnomedics GmbH. It received FDA 510(k) clearance on 2022-06-15 under 510(k) number K212325. The device is classified under product code GYB. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EEG-acp?

EEG-acp is a medical device that received FDA 510(k) clearance on 2022-06-15. The listed applicant is Somnomedics GmbH. The 510(k) number is K212325.

When did EEG-acp receive FDA 510(k) clearance?

EEG-acp received FDA 510(k) clearance on 2022-06-15, under 510(k) number K212325.

Who is the listed applicant for EEG-acp?

The FDA 510(k) record lists Somnomedics GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EEG-acp?

The FDA product code for EEG-acp is GYB.

Other records listing Somnomedics GmbH as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GYB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.